openPR Logo
Press release

Fibromyalgia Treatment Market Global Industry Insights 2018-2026

08-09-2018 03:33 PM CET | Health & Medicine

Press release from: Coherent Market Insights

Fibromyalgia Treatment Market Global Industry Insights

Fibromyalgia is a common and complex chronic pain disorder that causes musculoskeletal pain, fatigue and localized tenderness affecting individuals mentally, physically and socially. Fibromyalgia is mainly caused due to genetic conditions, however actual cause is still unknown. The most common symptoms of fibromyalgia are fatigue, sleeping problems, chronic muscle pain and tender points. An individual with fibromyalgia can also have symptoms such as headaches, poor concentration and depression. Fibromyalgia symptoms can be gradually accumulated with the time or it can be done by some external factors. Fibromyalgia treatments include therapy, medications, regular aerobic exercise, stress reduction, and others. Furthermore, for treatment of Fibromyalgia antidepressants or pain medication are prescribed to treat depression, anxiety, pain, and fatigue.

Download PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/1691

Fibromyalgia Treatment Market: Market Dynamics

Increasing prevalence of Fibromyalgia is expected to augment market growth. According to National Fibromyalgia and Chronic Pain Association, 2014, an estimated 210 million people in 2015, were affected with fibromyalgia syndrome, accounting for 2-4% of the total world population. Moreover, growth of the market is driven by increasing clinical trials by the manufacturers and research organizations and launch of novel diagnostics in order to reduce the burden of the disease with early and accurate disease diagnosis. For instance, in 2013, Innovative Med Concepts, LLC initiated the clinical trial for the drug candidate IMC-1, for the treatment of patients with fibromyalgia. Also, in March 2018, IQuity, a data science company launched a new blood test called Isolate Fibromyalgia, which uses RNA gene expression analysis to detect fibromyalgia, thus aiding in efficient diagnostics, which can provide early medical intervention.

Furthermore, various organizations are supporting research and development and providing accessible, affordable, and appropriate treatment which is expected to augment the market growth over the forecast period. For instance, a non-profit organization named National Fibromyalgia and Chronic Pain Association (NFMCPA) aims to build a united patient and health care community educate and execute advocacy programs regarding access to care, research, diagnosis and treatment for people suffering with chronic pain from fibromyalgia and overlapping conditions.

However, the difficulty to diagnose fibromyalgia since most of the symptoms are associated with other diseases, reduces the rate of diagnosis of patients with fibromyalgia, thereby hindering the growth of fibromyalgia treatment market.

Fibromyalgia Treatment Market: Regional Dynamics

Regional segmentation of the global fibromyalgia treatment market by Coherent Market Insights comprises North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to hold a dominant position in the global fibromyalgia treatment market, owing to increasing incidence of fibromyalgia and to curb the economic burden associated with the disease in the U.S. According to the National Fibromyalgia Association, 2015, fibromyalgia affects an estimated 10 million people in the U.S. Moreover, according to the Community Pain Center, Fibromyalgia is responsible for a decrease in productivity by 1-2%, resulting in direct and indirect expenditures of US$ 15 billion in the U.S., thus impelling the organizations and manufacturers to launch efficient therapies, which in turn is expected to bolster the fibromyalgia treatment market in the region.

The Fibromyalgia treatment market in Europe is expected to gain significant traction, owing to the presence of support groups providing online support combined with fund raising activities to make treatments available for the patients. For instance, the Fibromyalgia Action UK improves the lives of people with fibromyalgia by increasing awareness of the condition throughout the country, thereby improving awareness and access to treatments for fibromyalgia. Also, the UK Fibromyalgia, a member of Disability Rights UK, is focused on spreading awareness regarding Fibromyalgia condition through magazines and social media accounts, as well as encourages National Health Society (NHS) and private organizations to invest in new research projects.

Request Sample Copy of this Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/1691

Fibromyalgia Treatment Market: Competitive Landscape

The key players in Fibromyalgia treatment market are focusing on developing innovative solutions to treat generalized pain associated with fibromyalgia. For instance, in October 2017, Avacen Medical launched an Avacen 100 Class II, which provides provide non-invasive, rapid whole-body treatment, using a single point of contact. Avacen treatment method is a novel concept in the chronic pain treatment that safely and non-invasively infuses heat into the circulatory system to generate muscular relaxation, thus providing an ideal drug-free and safe alternative for pain relief.

Key players operating in the global fibromyalgia treatment market include Eli Lilly and Company, Pfizer Inc., Merck & Co., Johnson & Johnson, GlaxoSmithKline Plc., Novartis AG, Sanofi S.A., AstraZeneca, and Allergan Plc.

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Fibromyalgia Treatment Market Global Industry Insights 2018-2026 here

News-ID: 1171310 • Views: 495

More Releases from Coherent Market Insights

Metal and Ceramic Injection Molding market Is Projected To Reach US$ 7,675.1 mil …
Metal and ceramic injection molding are technologically advanced manufacturing processes used in the production of the different complex and precision components. Metal and ceramic injection molding together called powder injection molding (PIM). This technology provides flexibility in design for numerous choices of materials. The market for global metal and ceramic injection molding is forecast to surpass US$ 7,675.1 million by 2027 witnessing a CAGR of 11.5% between 2020 and 2027. Coherent Market
Sustainable Bioenergy Market Emerging Trend, Advancement, Growth and Business Op …
Bioenergy is defined as the material which is produced by photosynthesis and it is used a feedstock in the manufacturing of fuels and substitutes for petrochemical & other energy intensive products. According to United Nations, sustainable energy is defined as energy that meets the needs of the present without compromising the ability of future generations to meet their own needs. Coherent Market Insights' Sustainable Bioenergy insightful study provides a comprehensive review
Tire Chord and Tire Fabrics market Is Projected To Rise At A Cagr Of 5.5% During …
Tire cords and tire fabrics are fabrics manufactured by using superior quality yarns. These cords and fabrics have better abrasion resistance, high tensile strength, controlled deformation, etc. They are majorly used across the tire industry especially in a rubber hose, air springs, and expansion joints. Polyester, steel, nylon, and rayon chords are some of the tire cords. The market for tire cord and tire fabrics is estimated to surpass US$ 7,386.7
Peracetic Acid market Growing At A Cagr Of 4.6 % From 2020-2027 | Kemira Oyj, So …
Peracetic acid is a liquid chemical product that is highly acidic in nature. It is produced by using hydrogen peroxide and acetic acid. It is considered as one of the most effective agents after ozone. It is widely used across disinfectant applications across various industries especially food industry for cleaning the equipment. The global peracetic acid market was accounted for US$ 606.8 Mn in terms of value in 2019 and is

All 5 Releases


More Releases for Fibromyalgia

Anticonvulsant Market for Fibromyalgia Competitive Analysis and Forecast 2017-20 …
Anticonvulsant Market for Fibromyalgia: Snapshot Anticonvulsant are pharmacological agents from a diverse group that are used for the treatment of epileptic seizures. Anticonvulsants are increasingly in demand on account of their use for the treatment of bipolar disorders. They are also used for the treatment of borderline personality disorder. Anticonvulsants act as stabilizers of mood and helps in the treatment of neuropathic pain. They suppress the rapid, excessive firing of neurons
Fibromyalgia Treatment Market Trends, Outlook, and Opportunity Analysis, 2018-20 …
Fibromyalgia is a common and complex chronic pain disorder that causes musculoskeletal pain, fatigue and localized tenderness affecting individuals mentally, physically and socially. Fibromyalgia is mainly caused due to genetic conditions, however actual cause is still unknown. The most common symptoms of fibromyalgia are fatigue, sleeping problems, chronic muscle pain and tender points. An individual with fibromyalgia can also have symptoms such as headaches, poor concentration and depression. Fibromyalgia symptoms
Fibromyalgia Treatment Market Global Opportunity Analysis, 2018-2026
Fibromyalgia is a common and complex chronic pain disorder that causes musculoskeletal pain, fatigue and localized tenderness affecting individuals mentally, physically and socially. Fibromyalgia is mainly caused due to genetic conditions, however actual cause is still unknown. The most common symptoms of fibromyalgia are fatigue, sleeping problems, chronic muscle pain and tender points. Request Sample Copy of this Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/1691 An individual with fibromyalgia can also have symptoms such
Anticonvulsant Market for Fibromyalgia Optimistic Opportunities 2025
Anticonvulsant Market for Fibromyalgia: Snapshot Anticonvulsants are pharmacological agents from a diverse group that are used for the treatment of epileptic seizures. Anticonvulsants are increasingly in demand on account of their use for the treatment of bipolar disorders. They are also used for the treatment of borderline personality disorder. Anticonvulsants act as stabilizers of mood and helps in the treatment of neuropathic pain. They suppress the rapid, excessive firing of neurons
Fibromyalgia Treatment Market | SWOT Analysis of Major Market Segments
Fibromyalgia disorder is characterized by musculoskeletal pain along with characteristics of fatigue, sleep disorders, memory and mood issues, irritable bowel syndrome, headaches, depression, and anxiety. It is believed that fibromyalgia alters the pain sensations mechanism controlled by the brain. An individual with fibromyalgia also can have symptoms such as tension headaches, migraine, temporomandibular joint (TMJ) disorders. Symptoms of fibromyalgia can be gradually accumulated with the time, or it can be
Fibromyalgia Therapeutics - Pipeline Analysis 2018
Fibromyalgia therapeutic pipeline is expected to experience a positive trend in the coming years. Prevalence of fibromyalgia is increasing due to very large number of patients suffering from lifestyle disease, psychological stress, trauma, tension, headaches, anxiety and depression. Some of the significant factors driving the pipeline for fibromyalgia include rising prevalence of fibromyalgia and the increasing health awareness among the population, globally. According to the National Fibromyalgia and Chronic Pain